ArticleJournal of medicinal chemistry2016

Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia.

Jesse J McClure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.